Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Edward Heilman, MD
Department of Dermatology, State University of New York
Principal Investigator - Jiang Yang, Ph.D.
Psoriasis Research Institute of Guangzhou
Study Director - Liping Yang, MD
Psoriasis Research Institute of Guangzhou
Study Chair - Peter J. Jenkin, MD
Dermatology Associates
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Department of Dermatology, State University of New York, Downstate Medical Center
New York, New York, United States
- Dermatology Associates
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Jun 2015
- Primary completion
- 14 Mar 2018
- Completion
- 30 Jun 2018
- Last update posted
- 25 Mar 2026
- Registered enrollment
- 88
- Registry id
- NCT03372811
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.